術中神経モニタリング市場規模、シェア、動向分析レポート：製品別、情報源別、タイプ別、地域別、セグメント別予測、2025年～2030年

術中神経モニタリング市場の成長と動向：

世界の術中神経モニタリング市場規模は、2030年には46億6,000万米ドルに達すると予測され、予測期間中のCAGRは5.97%で成長すると予測されています。

この成長は、技術の進歩、デバイスの安全性に関する意識の高まり、老人人口の増加に起因しています。COVID-19の発生は市場に二重の影響を与えると予想されます。2020年3月、米国外科学会（ACS）は、米国でCOVID-19の症例が急速に増加したため、選択的手術の縮小、延期、中止を提案する声明を発表したが、これが成長の妨げになると予想されます。

さらに、エルゼビア誌に掲載された調査（国際出血性脳卒中協会；2021年1月）によると、入院したCOVID-19患者の最大36％が神経症状を示す可能性があり、虚血性・出血性梗塞に関連する症例が複数あった。さらに、2021年6月にNeurology Online Journalに掲載された別の最近の調査では、COVID-19ウイルスが新たな神経疾患の発症に関与している可能性が示唆されています。新しい疾患の増加により、院内死亡のリスクが高くなり、退院率が低下しています。これらの特徴は、予測期間中に有利な成長をもたらすと予想されます。

さらに、脳神経外科手術の件数と手ごろな価格の増加、手術における患者の安全性の重視の高まりにより、同市場は成長が見込まれています。術中神経モニタリング（IONM）は、再手術の回数を減らし、術後の合併症や後遺症の発生を減らすことができるため、病院は幅広い手術に採用しています。

術中神経モニタリング市場レポート・ハイライト

• タイプ別では、2024年にイン情報源セグメントが52.72%の最大シェアを占めました。これは、IONMの利点について患者だけでなく医師の間でも認識が高まっており、その結果、病院が複雑な手術中にIONMを利用するようになったためと考えられます。これが、同市場におけるIONMの優位性の主な理由です。
• 地域別では、北米が2024年に49.35%の最大シェアを占めました。有利な償還シナリオと技術の進歩がこの優位性の要因です。
• 欧州の術中神経モニタリング市場は、予測期間中にCAGR 6.38％で急成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 術中神経モニタリングの変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 術中神経モニタリング分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 術中神経モニタリング市場- セグメント分析、製品別、2018年-2030年

• 術中神経モニタリング市場：製品の展望と重要なポイント
• 術中神経モニタリング市場：製品変動分析
• 製品別
• システム
  • システム市場収益推計と予測、2018年-2030年
• 使い捨て
  • EMGチューブと電極
  • ステッカー電極
  • 刺激プローブ

第5章 術中神経モニタリング市場- セグメント分析、情報源別、2018年-2030年

• 術中神経モニタリング市場：情報源の展望と重要なポイント
• 術中神経モニタリング市場：情報源変動分析
• 情報源別
• インソース
  • インソース市場収益推計と予測、2018年-2030年
• アウトソース
  • アウトソース市場収益推計と予測、2018年-2030年

第6章 術中神経モニタリング市場- セグメント分析、タイプ別、2018年-2030年

• 術中神経モニタリング市場：タイプの展望と重要なポイント
• 術中神経モニタリング市場：タイプ変動分析
• タイプ別
• 断続的なモニタリング
  • 断続的モニタリング市場収益推計と予測、2018年-2030年
• 継続的な監視
  • 継続的モニタリング市場収益推計と予測、2018年-2030年

第7章 術中神経モニタリング市場：地域推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018年から2030年：
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要市場参入企業による最近の動向と影響分析
• 企業市場シェア分析、2024年
• 主要企業プロファイル
  • Natus Medical Incorporated
  • Medtronic
  • Accurate Monitoring
  • Neuromonitoring Technologies
  • NuVasive, Inc.
  • SpecialtyCare, LLC
  • Neurosoft
  • Ambu A/S
  • Brainlab（Dr. Langer Medical GmbH）
  • Welcony（Neurosign UK Ltd.）

List of Tables

• Table 1 List of abbreviation
• Table 2 North America intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 3 North America intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 4 North America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 5 North America intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 6 U.S. intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 9 Canada intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 11 Canada intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 12 Mexico intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 13 Mexico intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 14 Mexico intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 15 Europe intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 17 Europe intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 18 Europe intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 19 Germany intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 20 Germany intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 21 Germany intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 22 UK intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 23 UK intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 24 UK intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 25 France intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 26 France intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 27 France intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 28 Italy intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 29 Italy intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 30 Italy intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 31 Spain intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 32 Spain intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 33 Spain intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 34 Denmark intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 35 Denmark intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 36 Denmark intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 37 Sweden intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 38 Sweden intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 39 Sweden intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 40 Norway intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 41 Norway intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 42 Norway intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 47 China intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 48 China intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 49 China intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 50 Japan intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 51 Japan intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 52 Japan intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 53 India intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 54 India intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 55 India intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 56 South Korea intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 57 South Korea intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 58 South Korea intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 59 Australia intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 60 Australia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 61 Australia intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 62 Thailand intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 63 Thailand intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 64 Thailand intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 65 Latin America intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 66 Latin America intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 67 Latin America intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 68 Brazil intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 69 Brazil intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 70 Brazil intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 71 Argentina intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 72 Argentina intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 73 Argentina intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 74 MEA intraoperative neuromonitoring market, by region, 2018 - 2030 (USD Million)
• Table 75 MEA intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 76 MEA intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 77 MEA intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 78 South Africa intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 79 South Africa intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 80 South Africa intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 81 Saudi Arabia intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 84 UAE intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 85 UAE intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 86 UAE intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)
• Table 87 Kuwait intraoperative neuromonitoring market, by product, 2018 - 2030 (USD Million)
• Table 88 Kuwait intraoperative neuromonitoring market, by type, 2018 - 2030 (USD Million)
• Table 89 Kuwait intraoperative neuromonitoring market, by source, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1. Intraoperative neuromonitoring market segmentation
• Fig. 2. Market research process
• Fig. 3. Information procurement
• Fig. 4. Primary research pattern
• Fig. 5. Value chain based sizing & forecasting
• Fig. 6. Market formulation & validation
• Fig. 7. Market snapshot (global and regional)
• Fig. 8. Product type & application segment snapshot
• Fig. 9. Source segment snapshot
• Fig. 10. Competitive landscape snapshot
• Fig. 11. Porter's five forces analysis
• Fig. 12. PESTLE analysis
• Fig. 13. Intraoperative neuromonitoring market: Product outlook and key takeaways
• Fig. 14. Intraoperative neuromonitoring market: Product movement analysis
• Fig. 15. Intraoperative neuromonitoring market, for Systems, 2018 - 2030 (USD Million)
• Fig. 16. Intraoperative neuromonitoring market, for Disposables, 2018 - 2030 (USD Million)
• Fig. 17. Intraoperative neuromonitoring market, for EMG Tubes And Electrodes, 2018 - 2030 (USD Million)
• Fig. 18. Intraoperative neuromonitoring market, for Sticker Electrode, 2018 - 2030 (USD Million)
• Fig. 19. Intraoperative neuromonitoring market, for Stimulating Probes, 2018 - 2030 (USD Million)
• Fig. 20. Intraoperative neuromonitoring market: Source outlook and key takeaways
• Fig. 21. Intraoperative neuromonitoring market: Source movement analysis
• Fig. 22. Intraoperative neuromonitoring market, for Insourced, 2018 - 2030 (USD Million)
• Fig. 23. Intraoperative neuromonitoring market, for Outsourced, 2018 - 2030 (USD Million)
• Fig. 24. Intraoperative neuromonitoring market: Type outlook and key takeaways
• Fig. 25. Intraoperative neuromonitoring market: Type movement analysis
• Fig. 26. Intraoperative neuromonitoring market, for Intermittent Monitoring, 2018 - 2030 (USD Million)
• Fig. 27. Intraoperative neuromonitoring market, for Continuous Monitoring, 2018 - 2030 (USD Million)
• Fig. 28. Regional marketplace: Key takeaways
• Fig. 29. Regional marketplace: Key takeaways
• Fig. 30. North America intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 31. U.S. intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 32. Key country dynamics
• Fig. 33. Canada intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 34. Key country dynamics
• Fig. 35. Mexico intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 36. Key country dynamics
• Fig. 37. UK intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 38. Key country dynamics
• Fig. 39. Germany intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 40. Key country dynamics
• Fig. 41. France intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 42. Key country dynamics
• Fig. 43. Italy intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 44. Key country dynamics
• Fig. 45. Spain intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 46. Key country dynamics
• Fig. 47. Sweden intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 48. Key country dynamics
• Fig. 49. Denmark intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 50. Key country dynamics
• Fig. 51. Norway intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 52. Key country dynamics
• Fig. 53. Japan probes reprocessing market, 2018 - 2030 (USD Million)
• Fig. 54. Key country dynamics
• Fig. 55. China intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 56. Key country dynamics
• Fig. 57. India intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 58. Key country dynamics
• Fig. 59. Australia intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 60. Key country dynamics
• Fig. 61. South Korea intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 62. Key country dynamics
• Fig. 63. Thailand intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 64. Latin America intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 65. Key country dynamics
• Fig. 66. Brazil intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 67. Key country dynamics
• Fig. 68. Argentina intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 69. Key country dynamics
• Fig. 70. South Africa intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 71. Key country dynamics
• Fig. 72. Saudi Arabia intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 73. Key country dynamics
• Fig. 74. UAE intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 75. Key country dynamics
• Fig. 76. Kuwait intraoperative neuromonitoring market, 2018 - 2030 (USD Million)
• Fig. 77. Key company categorization
• Fig. 78. Strategic framework

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.66 billion in 2030 and is anticipated to grow at a CAGR of 5.97% over the forecast period. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

• By type, the insourced segment accounted for the largest share of 52.72% in 2024. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
• By region, North America accounted for the largest share of 49.35% in 2024. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
• The intraoperative neuromonitoring market in Europe is anticipated to grow fastest with a CAGR of 6.38% during the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Source
  • 1.2.3. Type
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for IONM in hospitals
    • 3.2.1.2. Technological advancements in intraoperative neuromonitoring systems
    • 3.2.1.3. Increasing prevalence of neurovascular disorders
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex regulatory framework
    • 3.2.2.2. Surgery-associated risk
• 3.3. Intraoperative Neuromonitoring Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Intraoperative Neuromonitoring Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 4.1. Intraoperative Neuromonitoring Market: Product Outlook and Key Takeaways
• 4.2. Intraoperative Neuromonitoring Market: Product Movement Analysis
• 4.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Product (USD Million)
• 4.4. Systems
  • 4.4.1. Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Disposables
  • 4.5.1.1. Disposables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. EMG Tubes And Electrodes
    • 4.5.2.1. EMG Tubes And Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Sticker Electrode
    • 4.5.3.1. Sticker Electrode Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Stimulating Probes
    • 4.5.4.1. Stimulating Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market - Segment Analysis, by Source, 2018 - 2030 (USD Million)

• 5.1. Intraoperative Neuromonitoring Market: Source Outlook and Key Takeaways
• 5.2. Intraoperative Neuromonitoring Market: Source Movement Analysis
• 5.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Source (USD Million)
• 5.4. Insourced
  • 5.4.1. Insourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Outsourced
  • 5.5.1. Outsourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intraoperative Neuromonitoring Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

• 6.1. Intraoperative Neuromonitoring Market: Type Outlook and Key Takeaways
• 6.2. Intraoperative Neuromonitoring Market: Type Movement Analysis
• 6.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Type (USD Million)
• 6.4. Intermittent Monitoring
  • 6.4.1. Intermittent Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Continuous Monitoring
  • 6.5.1. Continuous Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Recent Developments & Impact Analysis by Key Market Participants
• 8.3. Company Market Share Analysis, 2024
• 8.4. Key Company Profiles
  • 8.4.1. Natus Medical Incorporated
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Medtronic
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Accurate Monitoring
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Neuromonitoring Technologies
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. NuVasive, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. SpecialtyCare, LLC
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Neurosoft
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Ambu A/S
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Brainlab (Dr. Langer Medical GmbH)
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Welcony (Neurosign UK Ltd.)
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives